Switzerland offers non-mRNA Covid-19 vaccine alternative
The Swiss government has signed a contract with the American firm Janssen, part of the Johnson & Johnson group of companies, to purchase 150,000 doses of its Covid-19 vaccine, a viral vector model delivered in only one shot.
Cantons, which are responsible for organising vaccinations, are set to receive the vaccine early next week and will be able to offer the jab primarily to people who cannot be given the mRNA vaccine for medical reasons.
The vaccine was approved for use by medicine regulator Swissmedic in March. Until now the country had been offering two different vaccines in two doses to its population developed by Moderna and by Pfizer/BioNTech. These vaccines use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
By contrast, the Janssen vaccine can be administered in one shot and is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
According to the authorities, the vaccine offers “very good protection” against hospitalisation and severe forms of the illness. Johnson & Johnson have said that recent research shows the vaccine is even more effective when administered twice.
Not recommended for pregnant women
Christoph Berger, president of the Federal Vaccination Commission, told reporters in Bern that a very small minority — less than 100 people — may have an intolerance, such as a severe allergic reaction, to the mRNA vaccines.
The Commission and the federal public health office do not recommend the Janssen vaccine for pregnant women and people with immune deficiencies, who instead are advised to take the mRNA vaccines. The mRNA vaccines are also recommended for children aged 12 and older.
Berger said the Janssen vaccine is an alternative for people who are sceptical of mRNA shots. Compared to other European countries, vaccination uptake is relatively low in Switzerland, with around 58% of the population fully jabbed. A survey conducted in July by the research group Sotomo and reported by the SonntagsZeitung newspaper showed that most of the unvaccinated (72%) were holding out due to fears about mRNA technology.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Rhine flooding: Swiss to invest CHF1 billion with Austria
This content was published on
As part of an international agreement with Austria, the Swiss government wants to pump CHF1 billion ($1.1 billion) into flood protection measures along the Rhine over the next three decades.
Swiss government proposes CHF10 million UNRWA donation
This content was published on
After months of debate, Switzerland plans to give CHF10 million ($11 million) to the UN agency this year, rather than the CHF20 million initially foreseen.
Swiss study: insects mainly migrate at midday and dusk
This content was published on
A study led by the Swiss Ornithological Institute in canton Lucerne is helping to better understand the movement patterns of migratory insects.
Red Cross: 22 staff killed in Middle East since October
This content was published on
The Red Cross and Red Crescent network in Gaza and Israel has lost 22 staff members since last October, the Swiss Red Cross (SRC) said on Wednesday.
Dortmund’s Kobel is first Swiss goalie in Champions League final
This content was published on
Borussia Dortmund’s Gregor Kobel has achieved history by becoming the first Swiss goalkeeper to reach a Champion’s League final.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
Many Swiss could prefer wider vaccine choice, survey finds
This content was published on
The representative survey by research group Sotomo, reported in the SonntagsZeitung, was carried out in July, well before the introduction of the Covid certificate obligation this week. However, according to experts interviewed by the paper, it could be a sign that Switzerland’s vaccination campaign would be boosted by making available other jabs which don’t use…
This content was published on
Switzerland plans to boost its Covid-19 vaccination campaign over the summer with the aim to reach 80% of the population.
Health office advocates vaccine three months after Covid recovery
This content was published on
People who catch Covid-19 should get vaccinated three months after recovering and not six months, says the Swiss health office.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.